Articles related to OPIOIDS

AI-driven opioid monitoring systems are increasingly influencing medical decisions, but questions about their accuracy and potential bias persist. Learn how these tools could impact your practice and patient care.

Stay abreast of the latest trends in psychopharmacology, from the over-the-counter availability of Naloxone to the deadly rise of Xylazine and the ongoing tension between federal and state marijuana laws.

The alarming findings on nitazenes’ impact on cardiac arrest rates and naloxone dosage requirements demand your attention; further details could change how we approach opioid overdose treatments.

SIVAD Diagnostic Medical Group’s novel drug testing strips, HarmGuard FX, are making strides in harm reduction, beginning in Delaware. These strips, a part of the wider Harm Stopper Program, signal a potential turning point in the battle against the national opioid crisis.

As we grapple with the opioid crisis, this comprehensive study offers crucial insights into the intersection of state medical cannabis laws and chronic noncancer pain treatment, and posits no significant changes in pain treatment due to these laws.

The I-WOTCH trial offers insightful findings on multimodal interventions for opioid-dependent chronic pain patients. Read on for a detailed examination of the trial’s significant impact on patient wellbeing and opioid cessation.